683 Capital Management »

First Tracks Biotherapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 750k 20.12

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
NVIDIA Corporation Put Option (NVDA)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Capital One Financial (COF)
Abbvie Put Option (ABBV)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Anaptysbio Inc Common (ANAB)
Alnylam Pharmaceuticals (ALNY)
Uniqure Nv SHS (QURE)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Becton, Dickinson and (BDX)
Molina Healthcare (MOH)

View all positions for 683 Capital Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Bank of America Corporation
Sofinnova Ventures

View all funds holding First Tracks Biotherapeutics